Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
(applications tested for the base form of this product only)
THY1 / CD90 antibody was raised against xenogeneic rat thymocytes.
This antibody has been used to selectively remove cytotoxic T cells or their precursors, helper T cells and alloantigen activated proliferating T cells. Thy 1.1 is not present on T cells of most inbred mouse strains. In rats Thy1.1 is expressed on fibroblasts and bone marrow cells, but not on peripheral blood lymphocytes. This clone is cytotoxic with rabbit guinea pig complement. Species cross-reactivity: Recognizes both mouse and rat Thy1.1.
Suitable for use in Flow Cytometry and Complement Cytotoxicity. Flow Cytometry: 1:5.
PBS, 0.09% Sodium Azide
Short term: 4°C; Long term: Add glycerol (40-50%) -20°C.
THY1 or CD90 is a 25–37 kDa heavily N-glycosylated, glycophosphatidylinositol (GPI) anchored conserved cell surface protein with a single V-like immunoglobulin domain, originally discovered as a thymocyte antigen. Thy-1 can be used as a marker for a variety of stem cells and for the axonal processes of mature neurons.